KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
2.590
-0.020 (-0.77%)
At close: Mar 28, 2025, 4:00 PM
2.677
+0.087 (3.35%)
After-hours: Mar 28, 2025, 5:14 PM EDT
Company Description
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally.
It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.
The company was incorporated in 1980 and is based in Mahwah, New Jersey.
KORU Medical Systems, Inc.
| Country | United States |
| Founded | 1980 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 80 |
| CEO | Linda Tharby |
Contact Details
Address: 100 Corporate Drive Mahwah, New Jersey 07430 United States | |
| Phone | 800 624 9600 |
| Website | korumedical.com |
Stock Details
| Ticker Symbol | KRMD |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000704440 |
| CUSIP Number | 759910102 |
| ISIN Number | US7599101026 |
| Employer ID | 13-3044880 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Linda M. Tharby | President, Chief Executive Officer and Director |
| Thomas Adams | Chief Financial Officer, Secretary and Treasurer |
| Kenneth Miller | Chief Commercial Officer |
| Christopher Pazdan | Chief Operating Officer |
| Rob Cannon | Vice President of Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 19, 2025 | 144 | Filing |
| Mar 19, 2025 | 144 | Filing |
| Mar 17, 2025 | 144 | Filing |
| Mar 12, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Mar 12, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 12, 2025 | 10-K | Annual Report |
| Mar 12, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Jan 21, 2025 | SCHEDULE 13D/A | Filing |
| Jan 13, 2025 | 8-K | Current Report |